Pharmacovigilance and Drug Safety

Pharmacovigilance (PV) is defined as the science and events relating to the detection, assessment, understanding and prevention of adverse effects or any other drug-related problem. WHO established that one Programme for International Drug Monitoring in response to the thalidomide disaster detected in 1961.The aims of PV are to enhance patient care and patient safety in relation to the use of medicines.

  • Drug safety
  • Clinical and preclinical trails
  • Bioassay and its types
  • Bioassay and its types
  • Pharmacovigilance and Risk Management

Related Conference of Pharmacovigilance and Drug Safety

May 05-06, 2025

19th World Drug Delivery Summit

Vancouver, Canada
June 16-17, 2025

3rd Global Online Summit on Nanoscience and Nanotechnology

Zurich, Switzerland
June 23-24, 2025

38th World Congress on Pharmacology

Paris, France
August 18-19, 2025

40th World Congress on Pharmacology and Therapeutics

Valencia, Spain
September 22-23, 2025

Pharma Biotech Expo

Toronto, Canada
September 23-24, 2025

10th International Conference on Future Pharma and Innovations

Amsterdam, Netherlands
November 20-21, 2025

21st Annual Congress on Pharmacology and Toxicology

Aix-en-Provence, France
November 27-28, 2025

4th World Congress on Precision and Personalized Medicine

Zurich, Switzerland
November 27-28, 2025

13th International Conference on Clinical Trials

Amsterdam, Netherlands
November 27-28, 2025

4th World Conference on Pharma Industry and Medical Devices

Zurich, Switzerland

Pharmacovigilance and Drug Safety Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in